Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LIPOSOME COMPANY ESTABLISHES PRINCETON LIPIDS

Executive Summary

LIPOSOME COMPANY ESTABLISHES PRINCETON LIPIDS division to supply purified phospholipids to the cosmetics industry. "Because of its affiliation with the Liposome Company, Princeton Lipids will be able to provide technical expertise in the field of liposomes to its customers," a Feb. 21 press release declares. The new unit is the outgrowth of two recent agreements. The first, signed in December with the Japanese firm Nichiyu Liposome Co., makes the Liposome Company the exclusive North American agent for Nichiyu Liposome Co.'s high purity phospholipid products. "Princeton Lipids will be one of the few U.S. companies capable of supplying commercial quantities of high purity lipids manufactured in a facility with a Drug Master File." The Liposome Company also serves as the North American sales agent for Nattermann Phospholipid GmbH under a more recent pact. "Princeton Lipids will be selling 'Naptides,'" described by the company as a liposome used in Europe as a raw material in cosmetic formulations. The U.S. market for liposome-formulated cosmetics is estimated at over $50 mil. in 1989. The development comes less than one week after the announcement of a proposed merger between the Liposome Company and Liposome Technology.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS015165

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel